Graphdiyne oxide nanosheets reprogram immunosuppressive macrophage for cancer immunotherapy
Nano Today(2022)
Abstract
Graphdiyne oxide (GDYO) nanosheets have remarkable electronic, mechanical, and thermal properties, which is hoped to act a better alternative for biomedical applications. Tumor-associated macrophage (TAM) is a promising cell population for nanotechnology application to cancer immunotherapy. In the present study, we found M2-like macrophages can be polarized to kill cancer cells with GDYO treatment via activation of pro-inflammatory pathways and GDYO injected intraperitoneally reduced tumor growth in a melanoma-bearing mouse model. In addition, GDYO activated cytotoxic T cells either directly or indirectly via macrophages, enhancing checkpoint inhibitor response in a breast cancer model. We expect that GDYO has invoked both the innate and adaptive arms of the immune system that are likely to enhance efficacy of cancer immunotherapy.
MoreTranslated text
Key words
Graphdiyne oxide,Macrophage polarization,T cell,Cancer immunotherapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined